Clinical Trial Update: PIK3CA Mutational Status Assessment

View source ↗

Summary

An ongoing clinical trial is evaluating PIK3CA mutational status in metastatic breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer Metastatic | Status: RECRUITING